veledimex: Clinical Trials

4 trials of veledimex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 12Terminated 2

Follow veledimex: new trials by email Literature Review of veledimex trials Research Report on veledimex

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
FCX-013, veledimex - Morphea, Scleroderma, Localized
Phase 1 / Phase 2TerminatedCastle Creek Biosciences, LLC.12019-12-182024-01-23
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc - Glioblastoma
Phase 2TerminatedAlaunos Therapeutics402019-08-012025-04-18
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
Ad-RTS-hIL-12, Veledimex - Metastatic Breast Cancer
Phase 1 / Phase 2TerminatedAlaunos Therapeutics92015-07-182025-08-28
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.
Ad-RTS-hIL-12 and Veledimex, Palifosfamide - Breast Cancer Nos Metastatic Recurrent
Phase 2TerminatedAlaunos Therapeutics122013-04-042025-08-28

Conditions studied

Breast Neoplasms (2)  ·  Glioblastoma (1)  ·  Scleroderma, Diffuse (1)  ·  Scleroderma, Localized (1)

Sponsors

Alaunos Therapeutics (3)  ·  Castle Creek Biosciences, LLC. (1)

Countries

United States (4)

Top investigators

Jaymes Holland (3)

Results publications

PMID 34850166